Scientists hunt for DNA clues to target prostate cancer treatment
NCT ID NCT06600802
Summary
This study aims to identify molecular markers in tumor DNA that can predict which patients with advanced, treatment-resistant prostate cancer will respond to a targeted radiation therapy called Lu-PSMA. Researchers will analyze tumor samples from 120 men already scheduled to receive this treatment to look for specific genetic patterns linked to better outcomes. The goal is to develop a future test to help doctors personalize treatment decisions for this serious cancer.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CASTRATION-RESISTANT METASTATIC PROSTATE CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
CHU de Grenoble
NOT_YET_RECRUITINGLa Tronche, 38700, France
Contact
-
Centre Jean PERRIN
RECRUITINGClermont-Ferrand, 63011, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
Centre Paul STRAUSS
NOT_YET_RECRUITINGStrasbourg, 67091, France
Contact
-
Hospices Civiles de Lyon
NOT_YET_RECRUITINGPierre-Bénite, 69310, France
Contact
-
Hôpital privé de la Loire
NOT_YET_RECRUITINGSaint-Etienne, 42100, France
Contact
Conditions
Explore the condition pages connected to this study.